Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. External Links
  9. Analytics And Tracking
  10. Libraries
  11. Hosting Providers
  12. CDN Services

We began analyzing https://jtd.amegroups.org/article/view/50178/html, but it redirected us to https://jtd.amegroups.org/article/view/50178/html. The analysis below is for the second page.

Title[redir]:
Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma - Shen - Journal of Thoracic Disease
Description:
Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Insurance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, but we identified it was custom coded using Bootstrap (CSS).

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 75,536,609 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

patients, cancer, neoadjuvant, lung, surgery, study, treatment, chemotherapy, crossref, pubmed, pembrolizumab, stage, therapy, resectable, response, journal, pathological, cell, medicine, nsclc, oncol, annals, resection, cases, survival, immunotherapy, disease, tumor, rate, trial, nonsmallcell, lusc, pcr, postoperative, evaluation, followup, aes, advanced, hospital, research, regimen, surgical, complete, criteria, efficacy, chemoimmunotherapy, pdl, cycles, complications, tumors,

Topics {✒️}

strobe reporting checklist facebook share case report form video-assisted thoracoscopy small-cell lung cancer precision medicine journal small-cell lung cancers translational medicine art drugs targeting t-cell iib–iiib lusc open access statement egfr-mutant lung cancer gastrointestinal oncology journal consolidation immuno-oncology therapy reverse kaplan-meier method determine progression-free survival maxillofacial anesthesia journal anti-pd-1 therapy based resectable lung cancer pd-l1 sequential treatment stage iiia–n2 disease acceptable side-effect profile recurrence-free survival—defined stage iiib cases programmed cell death lung adenocarcinoma cancer previous medical treatment palliative medicine annals breast surgery annals lung cancer surgery indicating pathological assessment lung cancer-reply severe intraoperative complications updated clinical research iiib lusc evaluated ethical statement health policy journal major pathological response surgery australian journal spine surgery journal visualized surgery journal neoadjuvant therapy-related aes pd-l1 level pd-l1-positive kaplan–meier method programmed death-ligand 1 nasopharynx cancer annals pancreatic cancer annals resected lung cancer surgical resection prior

External Links {🔗}(204)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • AOS
  • Bootstrap
  • jQuery
  • Modernizr
  • Video.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Amegroups
  • Crossref

8.83s.